Britannia Life Sciences IncCanadian Securities Exchange:BLABView on OTC Pink - Current Information
- LAST PRICE0.0700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0600/ 41
- Ask / Lots0.0800/ 80
- Open / Previous Close0.0000 / 0.0700
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | BLAB |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Britannia Life Sciences Inc | 11.4M | 6.7x | --- |
Promino Nutritional Sciences Inc | 12.4M | -1.4x | --- |
Blender Bites Ltd | 12.3M | -1.0x | --- |
Good Flour Corp | 12.7M | -2.0x | --- |
Nextgen Food Robotics Corp | 10.4M | -2.0x | --- |
Emergence Global Enterprises Inc | 4.9M | -7.8x | --- |
Company Information
Britannia Life Sciences Inc. is a Canada-based vertically diversified product development, quality assurance and safety and regulatory compliance company. The Company’s platform offers an integrated suite of services to assist companies along their product development journey. The Company provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. It is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations. Its services include product formulations, safety assessments, analytical and microbiological testing, global compliance, and consumer evaluations are offered to companies. It serves consumer-packaged goods (CPG), cosmetics, household goods, nutraceutical industries, notable multinationals, retailers, brands, blue-chip and small and medium enterprise clients.
Contact Information
- Headquarters
- 120 Adelaide Street West; Suite 2400TORONTO, ON, Canada M5H 1T1
- Phone
- 416-930-7711
- Fax
- 416-302-0779
Executives
- Independent Chairman of the Board
- Greg Taylor
- Chief Executive Officer, Director
- Peter Shippen
- Chief Financial Officer, Company Secretary
- Sarah Zilik
- Chief Technology Officer
- Mark Bowes-cavanagh
- Independent Director
- Scott Secord
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.4M |
|---|---|
Revenue (TTM) | $7.5M |
Shares Outstanding | 162.3M |
Britannia Life Sciences Inc does not pay a dividend. | |
Beta | 3.79 |
EPS | $0.01 |
Book Value | $0.04 |
P/E Ratio | 6.7x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | 5.3x |
Operating Margin | 6.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
